Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. NBP149695E

Novus Biologicals™ Lgr6 Antibody Blocking Peptide
SDP

Catalog No. NBP149695E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.25 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP149695E 0.25 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP149695E Supplier Novus Biologicals™ Supplier No. NBP149695PEP
Only null left
Add to Cart
Add to Cart

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A peptide corresponding to amino acids 840 - 900 of human LGR6. The Lgr6 Blocking Peptide is derived from Synthetic. The Lgr6 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 59352
Species Human
Purity >85%, by HPLC
Accession Number CAI15929
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation Sodium Bicarbonate buffer, pH 8.00 containing up to 10% DMSO
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-49695. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias FLJ14471, gonadotropin receptor, GPCR, leucine-rich repeat containing G protein-coupled receptor 6, leucine-rich repeat-containing G protein-coupled receptor 6, leucine-rich repeat-containing G-protein coupled receptor 6, VTS20631
Gene Symbol LGR6
Product Type Lgr6
Quantity 0.25 mg
Regulatory Status RUO - research use only
Termination Synthetic peptides corresponding to unique epitope on Lgr6 The peptide sequence corresponding to amino acids 860-915 of the human Lgr6 protein, the peptide was post-synthetically modified to achieve desired antigenicity before coupling to a carrier prot
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.